Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 1/2022

11.02.2021 | Original Article

Reference intervals for commonly requested biochemical and haematological parameters in a healthy Irish adult Caucasian population

verfasst von: Md Nahidul Islam, Tomás P. Griffin, Robert Whiriskey, Siobhan Hamon, Brendan Cleary, Liam Blake, Damian G. Griffin, Matthew D. Griffin, Janusz Krawczyk, Paula M. O’Shea

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

In laboratory medicine, reference intervals (RIs) are key decision support tools used to guide the clinical interpretation of numerical test results. Best practice suggests each laboratory establishes RIs in the local population prior to introducing an assay into routine clinical practice.

Aim

The aim of this study was to define RIs for frequently requested biochemical/haematological parameters in a healthy adult Irish Caucasian population.

Methods

A cross-sectional study of non-pregnant apparently healthy volunteers was conducted. Baseline demographics, anthropometric and laboratory measurements were recorded. In total, 37 commonly requested biochemical (serum, n = 26) and haematological (venous blood, n = 11) ISO15189:2012 accredited tests were analysed, using the Roche Cobas® Sebia Capillarys 3 Tera and Siemens Advia® 2120i platforms following standard operating procedures. RIs were defined according to the International Federation of Clinical Chemistry (IFCC) recommended method.

Results

Of 208 apparently healthy volunteers, 76 failed to meet the study inclusion criteria. The reference population comprised of 132 participants (males: n = 65, 49.2%) with a median age of 29.7 (18.1–62.2) years. RIs for the majority of biochemical/haematological parameters were broadly in accord with those provided by Pathology Harmony (UK)/Irish RI Harmonisation Project and the manufacturer Roche Diagnostics. However, the established RI defined for HbA1c: 27–37 mmol/mol was markedly different from that quoted nationally, HbA1c: 20–42 mmol/mol.

Conclusion

Normative biological intervals established in a healthy adult Irish population for 37 commonly requested biochemical/haematological parameters will be a valuable aid to result interpretation in clinical laboratories after appropriate verification in accordance with ISO 15189: 2012.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ceriotti F, Henny J (2008) “Are my laboratory results normal?” Considerations to be made concerning reference intervals and decision limits. EJIFCC 19(2):106–114PubMedPubMedCentral Ceriotti F, Henny J (2008) “Are my laboratory results normal?” Considerations to be made concerning reference intervals and decision limits. EJIFCC 19(2):106–114PubMedPubMedCentral
2.
Zurück zum Zitat Beastall GH (2013) Adding value to laboratory medicine: a professional responsibility. Clin Chem Lab Med 51(1):221–227CrossRef Beastall GH (2013) Adding value to laboratory medicine: a professional responsibility. Clin Chem Lab Med 51(1):221–227CrossRef
3.
Zurück zum Zitat Hallworth MJ (2011) The ‘70% claim’: what is the evidence base? Ann Clin Biochem 48(Pt 6):487–488CrossRef Hallworth MJ (2011) The ‘70% claim’: what is the evidence base? Ann Clin Biochem 48(Pt 6):487–488CrossRef
4.
Zurück zum Zitat Solberg HE (1986) Statistical treatment of reference values in laboratory medicine: testing the goodness-of-fit of an observed distribution to the Gaussian distribution. Scand J Clin Lab Invest Suppl 184:125–132PubMed Solberg HE (1986) Statistical treatment of reference values in laboratory medicine: testing the goodness-of-fit of an observed distribution to the Gaussian distribution. Scand J Clin Lab Invest Suppl 184:125–132PubMed
5.
Zurück zum Zitat Thygesen K, Alpert JS, Jaffe AS et al (2018) Fourth universal definition of myocardial infarction 2018. Circulation 138(20):e618–e651CrossRef Thygesen K, Alpert JS, Jaffe AS et al (2018) Fourth universal definition of myocardial infarction 2018. Circulation 138(20):e618–e651CrossRef
6.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRef Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRef
7.
Zurück zum Zitat Nordestgaard BG, Langsted A, Mora S et al (2016) Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 37(25):1944–1958CrossRef Nordestgaard BG, Langsted A, Mora S et al (2016) Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 37(25):1944–1958CrossRef
11.
Zurück zum Zitat Research on healthy volunteers (1986) A report of the Royal College of Physicians. J R Coll Physicians Lond 20(4):243–257 Research on healthy volunteers (1986) A report of the Royal College of Physicians. J R Coll Physicians Lond 20(4):243–257
12.
Zurück zum Zitat CLSI (2008) Clinical and Laboratory Standards Institute EP28-A3c. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline—third edition. Wayne, PA: 2008 CLSI (2008) Clinical and Laboratory Standards Institute EP28-A3c. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline—third edition. Wayne, PA: 2008
13.
Zurück zum Zitat ISO15189 (2012) Medical laboratories—requirements for quality and competence. 3 ed. Geneva, Switzerland: International Organization for Standardization ISO15189 (2012) Medical laboratories—requirements for quality and competence. 3 ed. Geneva, Switzerland: International Organization for Standardization
16.
Zurück zum Zitat Berg J, Lane V (2011) Pathology harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory. Ann Clin Biochem 48(Pt 3):195–197CrossRef Berg J, Lane V (2011) Pathology harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory. Ann Clin Biochem 48(Pt 3):195–197CrossRef
17.
Zurück zum Zitat Koerbin G, Tate JR (2016) Harmonising adult reference intervals in Australia and New Zealand—the continuing story. Clin Biochem Rev 37(3):121–129PubMedPubMedCentral Koerbin G, Tate JR (2016) Harmonising adult reference intervals in Australia and New Zealand—the continuing story. Clin Biochem Rev 37(3):121–129PubMedPubMedCentral
18.
Zurück zum Zitat Bian X, Griffin TP, Zhu X et al (2019) Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy. BMJ Open Diabetes Res Care 7(1):e000720CrossRef Bian X, Griffin TP, Zhu X et al (2019) Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy. BMJ Open Diabetes Res Care 7(1):e000720CrossRef
19.
Zurück zum Zitat Hamon SM, Griffin TP, Islam MN et al (2019) Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD). Clin Chem Lab Med 57(4):510–520CrossRef Hamon SM, Griffin TP, Islam MN et al (2019) Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD). Clin Chem Lab Med 57(4):510–520CrossRef
20.
Zurück zum Zitat Griffin TP, Islam MN, Wall D et al (2019) Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential. Sci Rep 9(1):18452CrossRef Griffin TP, Islam MN, Wall D et al (2019) Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential. Sci Rep 9(1):18452CrossRef
21.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219 Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219
22.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612CrossRef Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612CrossRef
23.
Zurück zum Zitat Tremblay AJ, Morrissette H, Gagne JM et al (2004) Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 37(9):785–790CrossRef Tremblay AJ, Morrissette H, Gagne JM et al (2004) Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 37(9):785–790CrossRef
24.
Zurück zum Zitat Burtis CA, Ashwood ER, Bruns DE et al (2008) TIETZ Fundamentals of Clinical Chemistry. 6 ed: Saunders Elsevier Burtis CA, Ashwood ER, Bruns DE et al (2008) TIETZ Fundamentals of Clinical Chemistry. 6 ed: Saunders Elsevier
25.
26.
Zurück zum Zitat Reed AH, Henry RJ, Mason WB et al (1971) Influence of statistical method used on the resulting estimate of normal range. Clin Chem 17(4):275–284CrossRef Reed AH, Henry RJ, Mason WB et al (1971) Influence of statistical method used on the resulting estimate of normal range. Clin Chem 17(4):275–284CrossRef
27.
Zurück zum Zitat Tukey JW (1977) Exploratory Data Analysis. . Reading, Mass. Addison-Wesley Pub. Co., ©1977. Tukey JW (1977) Exploratory Data Analysis. . Reading, Mass. Addison-Wesley Pub. Co., ©1977.
28.
Zurück zum Zitat Harris EK, Boyd JC (1990) On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 36(2):265–270CrossRef Harris EK, Boyd JC (1990) On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 36(2):265–270CrossRef
29.
Zurück zum Zitat Horn PS, Pesce AJ, Copeland BE et al (1998) A robust approach to reference interval estimation and evaluation. Clin Chem 44(3):622–631CrossRef Horn PS, Pesce AJ, Copeland BE et al (1998) A robust approach to reference interval estimation and evaluation. Clin Chem 44(3):622–631CrossRef
30.
Zurück zum Zitat Kwo PY, Cohen SM, Lim JK et al (2017) ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol 112(1):18–35CrossRef Kwo PY, Cohen SM, Lim JK et al (2017) ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol 112(1):18–35CrossRef
31.
Zurück zum Zitat Ceriotti F, Boyd JC, Klein G et al (2008) Reference intervals for serum creatinine concentrations: assessment of available data for global application. Clin Chem 54(3):559–566CrossRef Ceriotti F, Boyd JC, Klein G et al (2008) Reference intervals for serum creatinine concentrations: assessment of available data for global application. Clin Chem 54(3):559–566CrossRef
33.
Zurück zum Zitat Bain BJ, Bates I, Laffan MSL et al (2011) Reference ranges and normal values. In: Dacie and Lewis, editor. Practical Haematology 11th ed. London Churchill Livingstone; p. 14–7 Bain BJ, Bates I, Laffan MSL et al (2011) Reference ranges and normal values. In: Dacie and Lewis, editor. Practical Haematology 11th ed. London Churchill Livingstone; p. 14–7
35.
Zurück zum Zitat O’Connor C, O’Shea PM, Owens LA et al (2011) Trimester-specific reference intervals for haemoglobin A1c (HbA1c) in pregnancy. Clin Chem Lab Med 50(5):905–909 O’Connor C, O’Shea PM, Owens LA et al (2011) Trimester-specific reference intervals for haemoglobin A1c (HbA1c) in pregnancy. Clin Chem Lab Med 50(5):905–909
36.
Zurück zum Zitat Jeppsson JO, Kobold U, Barr J et al (2002) Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40(1):78–89CrossRef Jeppsson JO, Kobold U, Barr J et al (2002) Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40(1):78–89CrossRef
37.
Zurück zum Zitat Diabetes Control Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–86 Diabetes Control Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–86
38.
Zurück zum Zitat WHO (2021) Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva: World Health Organization; 2011. 2, Glycated haemoglobin (HbA1c) for the diagnosis of diabetes. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304271/. Accessed 20 Jan 2021 WHO (2021) Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva: World Health Organization; 2011. 2, Glycated haemoglobin (HbA1c) for the diagnosis of diabetes. Available from: https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK304271/​. Accessed 20 Jan 2021
39.
Zurück zum Zitat Hughes D, Crowley J, O'Shea P (2020) Lipid reference values in an Irish population. Ir J Med Sci Hughes D, Crowley J, O'Shea P (2020) Lipid reference values in an Irish population. Ir J Med Sci
Metadaten
Titel
Reference intervals for commonly requested biochemical and haematological parameters in a healthy Irish adult Caucasian population
verfasst von
Md Nahidul Islam
Tomás P. Griffin
Robert Whiriskey
Siobhan Hamon
Brendan Cleary
Liam Blake
Damian G. Griffin
Matthew D. Griffin
Janusz Krawczyk
Paula M. O’Shea
Publikationsdatum
11.02.2021
Verlag
Springer International Publishing
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 1/2022
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-021-02535-0

Weitere Artikel der Ausgabe 1/2022

Irish Journal of Medical Science (1971 -) 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.